Skip to main content
Michael Goodkin, MD, Cardiology, Media, PA

MichaelGoodkinMD

Cardiology Media, PA

Non-Invasive Cardiology

Physician

Dr. Goodkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goodkin's full profile

Already have an account?

  • Office

    1088 W Baltimore Pike
    Suite 2400
    Media, PA 19063
    Phone+1 610-565-2100
    Fax+1 610-892-0626

Summary

  • I am a retired noninvasive cardiologist.My daughter has POTS. I saw 400 patients and am on the medical advisory board of Standing Up To POTS. My daughter also has EDS and MCAS in which I have expertise.

    I have developed an interest in COVID. I am on the medical advisory board of Trialsite News where I have published 36 articles, mainly on repurposed drugs for COVID, especially ivermectin. I have irrefutable evidence of fraud in all 5 large randomized trials. The ACP, IDSA and ACC refuse to alert their members or the public.

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 1978 - 1980
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1975 - 1978
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1975

Certifications & Licensure

  • PA State Medical License
    PA State Medical License Active through 2016

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • COVID-OUT: Metformin Reduces Hospitalization & Death Associated with COVID-19 While Ivermectin a No Show but Regimen Questioned
    COVID-OUT: Metformin Reduces Hospitalization & Death Associated with COVID-19 While Ivermectin a No Show but Regimen QuestionedJuly 9th, 2022

Professional Memberships